المؤلفون: Heng Mei (325433), Xiaofan Liu (141518), Yan Li (23143), Hu Zhou (54222), Ying Feng (151159), Guangxun Gao (10199846), Peng Cheng (153428), Ruibin Huang (10054221), Linhua Yang (9330320), Jianda Hu (545445), Ming Hou (212172), Yazhou Yao (8213712), Li Liu (75607), Yi Wang (32470), Depei Wu (239078), Liansheng Zhang (4419775), Changcheng Zheng (10199849), Xuliang Shen (10199852), Qi Hu (516214), Jing Liu (38537), Jie Jin (52722), Jianmin Luo (211132), Yun Zeng (697507), Sujun Gao (530382), Xiaohui Zhang (81778), Xin Zhou (54275), Qingzhi Shi (10199855), Ruixiang Xia (1515925), Xiaobao Xie (379877), Zhongxing Jiang (9227675), Li Gao (131516), Yuansong Bai (10199858), Junye Xiong (10199861), Runzi Li (10199864), Jianjun Zou (6907025), Ting Niu (136108), Renchi Yang (5072249), Yu Hu (10199867)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Ecology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Immune thrombocytopenia, Hetrombopag, Thrombopoietin receptor agonists, Platelet response

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_multicenter_randomized_phase_III_trial_of_hetrombopag_a_novel_thrombopoietin_receptor_agonist_for_the_treatment_of_immune_thrombocytopenia/14121941

الاتاحة: https://doi.org/10.6084/m9.figshare.14121941.v1